6UYC

Crystal structure of TEAD2 bound to Compound 2


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.66 Å
  • R-Value Free: 0.216 
  • R-Value Work: 0.194 
  • R-Value Observed: 0.195 

wwPDB Validation   3D Report Full Report


This is version 1.1 of the entry. See complete history


Literature

Small Molecule Dysregulation of TEAD Lipidation Induces a Dominant-Negative Inhibition of Hippo Pathway Signaling.

Holden, J.K.Crawford, J.J.Noland, C.L.Schmidt, S.Zbieg, J.R.Lacap, J.A.Zang, R.Miller, G.M.Zhang, Y.Beroza, P.Reja, R.Lee, W.Tom, J.Y.K.Fong, R.Steffek, M.Clausen, S.Hagenbeek, T.J.Hu, T.Zhou, Z.Shen, H.C.Cunningham, C.N.

(2020) Cell Rep 31: 107809-107809

  • DOI: 10.1016/j.celrep.2020.107809
  • Primary Citation of Related Structures:  
    6UYC, 6UYB

  • PubMed Abstract: 
  • The transcriptional enhanced associate domain (TEAD) family of transcription factors serves as the receptors for the downstream effectors of the Hippo pathway, YAP and TAZ, to upregulate the expression of multiple genes involved in cellular proliferation ...

    The transcriptional enhanced associate domain (TEAD) family of transcription factors serves as the receptors for the downstream effectors of the Hippo pathway, YAP and TAZ, to upregulate the expression of multiple genes involved in cellular proliferation and survival. Recent work identified TEAD S-palmitoylation as critical for protein stability and activity as the lipid tail extends into a hydrophobic core of the protein. Here, we report the identification and characterization of a potent small molecule that binds the TEAD lipid pocket (LP) and disrupts TEAD S-palmitoylation. Using a variety of biochemical, structural, and cellular methods, we uncover that TEAD S-palmitoylation functions as a TEAD homeostatic protein level checkpoint and that dysregulation of this lipidation affects TEAD transcriptional activity in a dominant-negative manner. Furthermore, we demonstrate that targeting the TEAD LP is a promising therapeutic strategy for modulating the Hippo pathway, showing tumor stasis in a mouse xenograft model.


    Organizational Affiliation

    Department of Early Discovery Biochemistry, Genentech, South San Francisco, CA 94080, USA. Electronic address: cunningham.christian@gene.com.



Macromolecules
Find similar proteins by:  (by identity cutoff)  |  Structure
Entity ID: 1
MoleculeChainsSequence LengthOrganismDetailsImage
Transcriptional enhancer factor TEF-4 AB236Homo sapiensMutation(s): 0 
Gene Names: TEAD2TEF4
Find proteins for Q15562 (Homo sapiens)
Explore Q15562 
Go to UniProtKB:  Q15562
NIH Common Fund Data Resources
PHAROS:  Q15562
Protein Feature View
Expand
  • Reference Sequence
Small Molecules
Ligands 2 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
QLV
Query on QLV

Download Ideal Coordinates CCD File 
A, B
N-{5-[(E)-2-(4,4-difluorocyclohexyl)ethenyl]-6-methoxypyridin-3-yl}methanesulfonamide
C15 H20 F2 N2 O3 S
KJXYCXXAVTYSCU-ONEGZZNKSA-N
 Ligand Interaction
TRS
Query on TRS

Download Ideal Coordinates CCD File 
B
2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL
C4 H12 N O3
LENZDBCJOHFCAS-UHFFFAOYSA-O
 Ligand Interaction
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.66 Å
  • R-Value Free: 0.216 
  • R-Value Work: 0.194 
  • R-Value Observed: 0.195 
  • Space Group: C 1 2 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 123.422α = 90
b = 61.249β = 117.26
c = 80.206γ = 90
Software Package:
Software NamePurpose
PHENIXrefinement
PDB_EXTRACTdata extraction
ADDREFdata reduction
AutoPROCdata scaling
PHENIXphasing

Structure Validation

View Full Validation Report



Entry History 

Deposition Data

Revision History 

  • Version 1.0: 2020-06-24
    Type: Initial release
  • Version 1.1: 2020-07-08
    Changes: Database references